Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL Motifs as Determined by L/F Swapping
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The androgen receptor (AR) ligand-binding domain (LBD) binds FXXLF motifs, present in the AR N-terminal domain and AR-specific cofactors, and some LXXLL motifs of nuclear receptor coactivators. We demonstrated that in the context of the AR FXXLF motif many different amino acid residues at positions +2 and +3 are compatible with strong AR LBD interaction, although a preference for E at +2 and K or R at +3 was found. Pairwise systematic analysis of F/L swaps at +1 and +5 in FXXLF and LXXLL motifs showed: 1) F to L substitutions in natural FXXLF motifs abolished AR LBD interaction; 2) binding of interacting LXXLL motifs was unchanged or increased upon L to F substitutions; 3) certain noninteracting LXXLL motifs became strongly AR-interacting FXXLF motifs; whereas 4) other nonbinders remained unaffected by L to F substitutions. All FXXLF motifs, but not the corresponding LXXLL motifs, displayed a strong preference for AR LBD. Progesterone receptor LBD interacted with some FXXLF motifs, albeit always less efficiently than corresponding LXXLL motifs. AR LBD interaction of most FXXLF and LXXLL peptides depended on classical charge clamp residue K720, whereas E897 was less important. Other charged residues lining the AR coactivator-binding groove, K717 and R726, modulated optimal peptide binding. Interestingly, these four charged residues affected binding of individual peptides independent of an F or L at +1 and +5 in swap experiments. In conclusion, F residues determine strong and selective peptide interactions with AR. Sequences flanking the core motif determine the specific mode of FXXLF and LXXLL interactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Instead, it preferentially binds to a FXXLF motif existing in the AR NTD (Dubbink et al., 2006; Dubbink et al., 2004; He et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Dubbink et al., 2006
In the citing paper
“It prefers binding to the FXXLF sequence present in the NTD in contrast to what was seen with the ERα LBD (Dubbink et al., 2006; He et al., 2004; Hsu et al., 2003; Hur et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Dubbink et al., 2006
In the citing paper
“the AR LBD interacts weakly with LXXLL motif-containing coactivators, such as SRCs, (Brzozowski et al., 1997; Dubbink et al., 2006; He et al., 2004; He et al., 1999; Matias et al., 2000; Nadal et al., 2017).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Dubbink et al., 2006
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Improved method for high efficiency transformation of intact yeast cells
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. H. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,261
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
QUIGLEY, C. A., BELLIS, A. D., MARSCHKE, K. B., EL-AWADY, M. K., WILSON, E. M., & FRENCH, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,447
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Structure and specificity of nuclear receptor–coactivator interactions
Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., & Yamamoto, K. R. (1998) · Genes & Development · doi:10.1101/gad.12.21.3343 · Cited by 924
The nuclear receptor ligand-binding domain: structure and function
Moras, D., & Gronemeyer, H. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80015-x · Cited by 843
Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation
McInerney, E. M., Rose, D. W., Flynn, S. E., Westin, S., Mullen, T.-M., Krones, A., Inostroza, J., Torchia, J., Nolte, R. T., Assa-Munt, N., et al. (1998) · Genes & Development · doi:10.1101/gad.12.21.3357 · Cited by 613
He, B., Kemppainen, J. A., & Wilson, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002807200 · Cited by 442
Ding, X. F., Anderson, C. M., Ma, H., Hong, H., Uht, R. M., Kushner, P. J., & Stallcup, M. R. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.2.0065 · Cited by 434
Mechanism of the nuclear receptor molecular switch
NAGY, L. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.04.006 · Cited by 410
Chang, C.-Y., Norris, J. D., Grøn, H., Paige, L. A., Hamilton, P. T., Kenan, D. J., Fowlkes, D., & McDonnell, D. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8226 · Cited by 364
Wärnmark, A., Treuter, E., Wright, A. P. H., & Gustafsson, J.-A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0384 · Cited by 308
Mechanisms of androgen receptor activation and function
Brinkmann, A. O., Blok, L. J., de Ruiter, P. E., Doesburg, P., Steketee, K., Berrevoets, C. A., & Trapman, J. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00049-7 · Cited by 308
Self-citationHe, B., Gampe, R. T., Kole, A. J., Hnat, A. T., Stanley, T. B., An, G., Stewart, E. L., Kalman, R. I., Minges, J. T., & Wilson, E. M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.036 · Cited by 295
Steroid receptor induction of gene transcription: A two-step model
Jenster, G., Spencer, T. E., Burcin, M. M., Tsai, S. Y., Tsai, M.-J., & O’Malley, B. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7879 · Cited by 264
Self-citationTargeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
Scher, H. I., Buchanan, G., Gerald, W., Butler, L. M., & Tilley, W. D. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00525 · Cited by 240
Recognition and Accommodation at the Androgen Receptor Coactivator Binding Interface
Hur, E., Pfaff, S. J., Payne, E. S., Grøn, H., Buehrer, B. M., & Fletterick, R. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020274 · Cited by 234
Doesburg, P., Kuil, C. W., Berrevoets, C. A., Steketee, K., Faber, P. W., Mulder, E., Brinkmann, A. O., & Trapman, J. (1997) · Biochemistry · doi:10.1021/bi961775g · Cited by 209
Self-citationActivation of Nuclear Receptors
Li, Y., Lambert, M. H., & Xu, H. E. (2003) · Structure · doi:10.1016/s0969-2126(03)00133-3 · Cited by 191
The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators
He, B., Minges, J. T., Lee, L. W., & Wilson, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111975200 · Cited by 189
Estébanez-Perpiñá, E., Moore, J. M. R., Mar, E., Delgado-Rodrigues, E., Nguyen, P., Baxter, J. D., Buehrer, B. M., Webb, P., Fletterick, R. J., & Guy, R. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407046200 · Cited by 164
Heery, D. M., Hoare, S., Hussain, S., Parker, M. G., & Sheppard, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009404200 · Cited by 158
McEwan, I. J. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110281 · Cited by 156
Steketee, K., Timmerman, L., Ziel‐van der Made, A. C. J., Doesburg, P., Brinkmann, A. O., & Trapman, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10495 · Cited by 139
Self-citationDistinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor
Dubbink, H. J., Hersmus, R., Verma, C. S., van der Korput, H. A. G. M., Berrevoets, C. A., van Tol, J., Ziel-van der Made, A. C. J., Brinkmann, A. O., Pike, A. C. W., & Trapman, J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0375 · Cited by 118
Self-citationLeers, J., Treuter, E., & Gustafsson, J.-Å. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.6001 · Cited by 104
Hu, Y.-C., Yeh, S., Yeh, S.-D., Sampson, E. R., Huang, J., Li, P., Hsu, C.-L., Ting, H.-J., Lin, H.-K., Wang, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401781200 · Cited by 98
Hsu, C.-L., Chen, Y.-L., Yeh, S., Ting, H.-J., Hu, Y.-C., Lin, H., Wang, X., & Chang, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211908200 · Cited by 85
Evaluation of Ligand-Dependent Changes in AR Structure Using Peptide Probes
Chang, C.-Y. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.647 · Cited by 80
An Extended LXXLL Motif Sequence Determines the Nuclear Receptor Binding Specificity of TRAP220
Coulthard, V. H., Matsuda, S., & Heery, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212950200 · Cited by 77
Chang, C.-Y., Abdo, J., Hartney, T., & McDonnell, D. P. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0072 · Cited by 70
Structure-Activity Relationship of Nuclear Receptor-Ligand Interactions
Greschik, H., & Moras, D. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451736 · Cited by 58
Wang, L., Hsu, C.-L., Ni, J., Wang, P.-H., Yeh, S., Keng, P., & Chang, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2202-2213.2004 · Cited by 54
Steketee, K., Berrevoets, C. A., Dubbink, H. J., Doesburg, P., Hersmus, R., Brinkmann, A. O., & Trapman, J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03276.x · Cited by 48
Self-citationNorthrop, J. P., Nguyen, D., Piplani, S., Olivan, S. E., Kwan, S. T.-S., Go, N. F., Hart, C. P., & Schatz, P. J. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.5.0445 · Cited by 47
Ser-884 Adjacent to the LXXLL Motif of Coactivator TRBP Defines Selectivity for ERs and TRs
Ko, L. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.128 · Cited by 46
Cited by
Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
Yu, X., Yi, P., Hamilton, R. A., Shen, H., Chen, M., Foulds, C. E., Mancini, M. A., Ludtke, S. J., Wang, Z., & O’Malley, B. W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.031 · Cited by 154
Androgen receptor coregulators: recruitment via the coactivator binding groove
van de Wijngaart, D. J., Dubbink, H. J., van Royen, M. E., Trapman, J., & Jenster, G. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.007 · Cited by 122
Self-citationIdentification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor
Zhou, X. E., Suino-Powell, K. M., Li, J., He, Y., MacKeigan, J. P., Melcher, K., Yong, E.-L., & Xu, H. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085779 · Cited by 106
Molecular biology of androgen insensitivity
Jääskeläinen, J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.006 · Cited by 101
“On the other hand, binding of proteins to the cofactor-binding groove might affect binding of the ligand (Dubbink et al., 2006).”
Messner, E. A., Steele, T. M., Tsamouri, M. M., Hejazi, N., Gao, A. C., Mudryj, M. M., & Ghosh, P. (2020) · Biomedicines · doi:10.3390/biomedicines8100422 · Cited by 99
“It can also bind so e LXXLL otifs of coactivators [36].”
Background
Metadata
- Authors
- Dubbink, H. J., Hersmus, R., Pike, A. C. W., Molier, M., Brinkmann, A. O., Jenster, G., & Trapman, J.
- Affiliations
- Erasmus MC (NL)
- Departments of Pathology (H.J.D., R.H., M.M., J.T.), 3000 DR Rotterdam, The Netherlands;
- University of York (GB)
- Urology (G.J.), 3000 DR Rotterdam, The Netherlands;
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-08-01
- Volume
- 20
- Issue
- 8
- Pages
- 1742-1755
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2126628258
- Cited by
- 47
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 4 · 2019: 3 · 2018: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 5
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- androgen receptor, ligand-binding domain, LXXLL motif, nuclear receptor coactivators, peptide binding specificity, progesterone receptor, charged residues
- MeSH terms
- Binding Sites, Cells, Cultured, DNA Mutational Analysis, Humans, Leucine, Ligands, Models, Molecular, Peptides, Phenylalanine, Protein Binding, Protons, Receptors, Androgen, Transcription Factors, Transfection, Leucine Zippers, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Receptors, Cytoplasmic and Nuclear, Dimerization, Two-Hybrid System Techniques, Amino Acid Motifs, Protein Interaction Mapping, Histone Acetyltransferases, Nuclear Receptor Coactivator 2, Nuclear Receptor Coactivator 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.